Evidence map›Paper›PMID 26286794›Full record

ReviewMolecular imaging and biology2015

Combined PET/MRI: Multi-modality Multi-parametric Imaging Is Here: Summary Report of the 4th International Workshop on PET/MR Imaging; February 23-27, 2015, Tübingen, Germany.

D L Bailey, B J Pichler, B Gückel, H Barthel, A J Beer, J Bremerich, J Czernin, A Drzezga, C Franzius, V Goh and 13 more

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Molecular imaging and biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05282277 (Examining the Effects of Estradiol on Neural and Molecular Response to Rewards in Perimenopausal-Onset Anhedonia and Psychosis), which is not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05282277 phase4recruitingnot on this mapstarted 2022, after this paper: background citation

Examining the Effects of Estradiol on Neural and Molecular Response to Rewards in Perimenopausal-Onset Anhedonia and Psychosis

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2022 to 2026Enrolled103ConditionsDepression, Psychosis, AnhedoniaArmsTransdermal Estradiol, Micronized Progesterone, Matching Placebo Patch, Raclopride C11
3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Prospective head-to-head comparison ofEuropean journal of nuclear medicine and molecular imaging · 2017
    Trial
  2. Article
  3. Article
  4. Article
  5. NEMA NU2-2012 performance measurements of the United Imaging uPMR790: an integrated PET/MR system.European journal of nuclear medicine and molecular imaging · 2021
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Advances in PET/MR instrumentation and image reconstruction.The British journal of radiology · 2018
    Review
  14. Cardiovascular PET/MR: "Not the end but the beginning".Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2017
    Article
  15. Cardiovascular PET/MR imaging: Quo Vadis?Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2017
    Review
  16. Article
  17. RESOLUTE PET/MRI Attenuation Correction for O-(2-Frontiers in neuroscience · 2017
    Article
  18. Variations in PET/MRI Operations: Results from an International Survey Among 39 Active Sites.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

D L BaileyDepartment of Nuclear Medicine, Royal North Shore Hospital, Sydney, Australia.
B J PichlerWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Tübingen, Germany.
B GückelDepartment of Interventional and Diagnostic Radiology, Eberhard Karls University, Tübingen, Germany.
H BarthelDepartment of Nuclear Medicine, Leipzig University, Leipzig, Germany.
A J BeerDepartment of Nuclear Medicine, Ulm University, Ulm, Germany.
J BremerichCardiothoracic Section, Department of Radiology and Nuclear Medicine, University of Basel Hospital, Basel, Switzerland.
J CzerninDepartment of Molecular and Medical Pharmacology, UCLA, Los Angeles, USA.
A DrzezgaDepartment of Nuclear Medicine, University Hospital Cologne, Cologne, Germany.
C FranziusCentre of Morphological and Molecular Diagnostics (ZeMoDi), MR- and PET/MRI; Centre of Nuclear Medicine and PET/CT, Bremen, Germany.
V GohDivision of Imaging Sciences and Biomedical Engineering, King's College London, London, UK.
M HartenbachDivision of Nuclear Medicine, Medical University of Vienna, Vienna, Austria.
H IidaDepartment of Investigative Radiology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan.
A KjaerDepartment of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark.
C la FougèreDepartment of Nuclear Medicine and Molecular Imaging, Eberhard Karls University Tübingen, Tübingen, Germany.
C N LadefogedDepartment of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen, Denmark.
I LawDepartment of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen, Denmark.
K NikolaouDepartment of Interventional and Diagnostic Radiology, Eberhard Karls University, Tübingen, Germany.
H H QuickErwin L. Hahn Institute for MR Imaging, University of Duisburg-Essen, Essen, Germany.
O SabriDepartment of Nuclear Medicine, Leipzig University, Leipzig, Germany.
J SchäferDepartment of Interventional and Diagnostic Radiology, Eberhard Karls University, Tübingen, Germany.
M SchäfersDepartment of Nuclear Medicine, University Hospital Münster, Münster, Germany.
H F WehrlWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Tübingen, Germany.
T BeyerCenter for Medical Physics and Biomedical Engineering, General Hospital Vienna, Medical University Vienna, 4L, Waehringer Guertel 18-20, 1090, Vienna, Austria. thomas.beyer@meduniwien.ac.at.

Funding

Cancer Research UK 16463
6 · The paper itself

Abstract

This paper summarises key themes and discussions from the 4th international workshop dedicated to the advancement of the technical, scientific and clinical applications of combined positron emission tomography (PET)/magnetic resonance imaging (MRI) systems that was held in Tübingen, Germany, from February 23 to 27, 2015. Specifically, we summarise the three days of invited presentations from active researchers in this and associated fields augmented by round table discussions and dialogue boards with specific topics. These include the use of PET/MRI in cardiovascular disease, paediatrics, oncology, neurology and multi-parametric imaging, the latter of which was suggested as a key promoting factor for the wider adoption of integrated PET/MRI. Discussions throughout the workshop and a poll taken on the final day demonstrated that attendees felt more strongly that PET/MRI has further advanced in both technical versatility and acceptance by clinical and research-driven users from the status quo of last year. Still, with only minimal evidence of progress made in exploiting the true complementary nature of the PET and MRI-based information, PET/MRI is still yet to achieve its potential. In that regard, the conclusion of last year's meeting "the real work has just started" still holds true.

Indexed as

Magnetic Resonance ImagingMultimodal ImagingPositron-Emission TomographyGermanyHumansAttenuation correctionCardiologyHybrid imagingMolecular imagingMRIMulti-parametric imagingNeurologyOncologyPETPET/CTPET/MRIQuantification

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.